Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    18612426 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed PpPfs25/ISA51 and ScPvs25/ISA51 Vaccines for Malaria
Conditions: Plasmodium Falciparum;   Plasmodium Vivax Malaria
Intervention: Drug: PpPfs25/ISA51 &  ScPvs25/ISA51
2 Completed Safety and Immunogenicity Study of Plasmodium Vivax CS Derived Synthetic Peptides Formulated in Two Adjuvants
Condition: Malaria, Vivax
Interventions: Drug: Peptides (N,R&C) formulated in Montanide ISA 720;   Drug: Peptides (N,R&C) formulated in Montanide ISA 51;   Other: Placebo

Indicates status has not been verified in more than two years